Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-03-06 @ 6:11 PM
Study NCT ID:
NCT02329860
Status:
COMPLETED
Last Update Posted:
2024-01-22
First Post:
2014-12-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
APTN-III-HCC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |